Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse
- PMID: 21839739
- DOI: 10.1016/j.jim.2011.07.018
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse
Abstract
Regulatory T cells (Tregs) are of crucial importance to suppress graft versus host disease (GvHD) post allogeneic stem cell transplantation (SCT), but are also known to impair antitumor immunity. However, Treg longitudinal studies are rare and in this respect advanced flowcytometric approaches for Treg characterization are necessary. To investigate the relation of both the percentage and the absolute numbers of Tregs on GvHD or relapse we measured CD4(+)CD25(+/hi)CD127(lo/-) Tregs in 239 peripheral blood (PB) samples of 16 patients during the first two years post-SCT. A 10-color flowcytometric panel was established to evaluate Treg subpopulations and has been tested in ten healthy individuals. In patients we demonstrated a decrease in CD127 expression on T cells early post-SCT which increases during the first year. Moreover, Tregs reached higher absolute numbers in patients with GvHD≤grade I compared to those with GvHD grades II-IV. In contrast, the percentage of Tregs was significantly higher in patients with GvHD grades II-IV or disease relapse compared to those without GvHD. These patients fit into the range of healthy individuals where a median value of 7.5% and 6.4% of T helper cells were characterized as CD4(+)CD25(+/hi)CD127(lo/-) and CD4(+)CD25(+/hi) Tregs, respectively. Furthermore, Tregs could be further subdivided into 40% naïve, 51% central memory and 9% effector memory Tregs. Our results showed for the first time a downregulation of CD127 expression on T cells including Tregs in patients early post-SCT. Additionally, new insights into the recovery of Tregs regarding GvHD and relapse were provided.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.Ann Hematol. 2011 Feb;90(2):213-8. doi: 10.1007/s00277-010-1068-0. Epub 2010 Sep 22. Ann Hematol. 2011. PMID: 20859740
-
Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.Leuk Res. 2010 Sep;34(9):1158-68. doi: 10.1016/j.leukres.2010.03.017. Epub 2010 Apr 20. Leuk Res. 2010. PMID: 20409584
-
[Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].Nan Fang Yi Ke Da Xue Xue Bao. 2008 Apr;28(4):537-41. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18495584 Chinese.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6. Int Immunopharmacol. 2003. PMID: 12860168 Review.
Cited by
-
Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.Front Immunol. 2021 Feb 12;11:607180. doi: 10.3389/fimmu.2020.607180. eCollection 2020. Front Immunol. 2021. PMID: 33643294 Free PMC article.
-
Notch Signaling and Alloreactivity.Transplantation. 2016 Dec;100(12):2593-2600. doi: 10.1097/TP.0000000000001468. Transplantation. 2016. PMID: 27607530 Free PMC article. Review.
-
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation.PLoS One. 2017 Apr 11;12(4):e0175337. doi: 10.1371/journal.pone.0175337. eCollection 2017. PLoS One. 2017. PMID: 28399164 Free PMC article.
-
The role of regulatory T cells in the biology of graft versus host disease.Front Immunol. 2013 Jun 24;4:163. doi: 10.3389/fimmu.2013.00163. eCollection 2013. Front Immunol. 2013. PMID: 23805140 Free PMC article.
-
Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.Cell Mol Immunol. 2020 May;17(5):483-495. doi: 10.1038/s41423-019-0312-3. Epub 2019 Oct 29. Cell Mol Immunol. 2020. PMID: 31664223 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials